Organizing Committee
OCM Member
Vice President, Clinical Pharmacology
High Point Clinical Trials Center , USA
Biography :

Clayton Dehn is a clinical research physiologist with particular expertise in endocrine disorders, especially those related to fertility and metabolic disturbances. He is a co-inventor of a process and substance for disturbing the inheritance pattern of ion-channelopathic disorders by selectively disabling genetically undesirable sperm cells. He is also the sole author of the first publication cautioning against the risk of SGLT-inhibition inducing ketoacidosis in insulinopenic populations.Clay brings over 15 years of knowledge and experience as a clinical research professional in the pharmaceutical, device, and CRO industries. His experience spans across global drug development, medical affairs, pharmacovigilance and regulatory affairs, and he has a proven track record in building, managing and globalizing medical teams.

Research Interest :

Metabolic Sciences

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
General Queries
More details about
Copyright © 2018-2019 Allied Academies, All Rights Reserved.